Item View & Download Statistics: Central Nervous System Outcomes of Lazertinib Versus Gefitinib in Egfr-Mutated Advanced Nsclc: a Laser301 Subset Analysis
Geo Map
| Region | # |
|---|---|
| NA - North America | 24 |
| AS - Asia, other | 10 |
| EU - Europe | 4 |
| AF - Africa | 1 |
| OC - Oceania | 1 |
| Total | 40 |
| Country | # |
|---|---|
| US - United States of America | 22 |
| CN - China | 4 |
| DE - Germany | 2 |
| JP - Japan | 2 |
| AU - Australia | 1 |
| CA - Canada | 1 |
| ES - Spain | 1 |
| KR - Korea | 1 |
| MX - Mexico | 1 |
| MY - Malaysia | 1 |
| other - Other Country | 14 |
| Total | 50 |
| City | # |
|---|---|
| St Louis | 2 |
| Aliquippa | 1 |
| Frankfurt am Main | 1 |
| Guangzhou | 1 |
| Gwanak-gu | 1 |
| Hanover | 1 |
| Houston | 1 |
| Isla Mujeres | 1 |
| Los Angeles | 1 |
| New Westminster | 1 |
| other | 39 |
| Total | 50 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2 | 2 | 4 | 10 | 6 | 6 | 0 | 1 | 1 | 5 | 2 | 2 | 41 |
| 2025 | 0 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Ever | 50 | ||||||||||||